One of the big challenges for average investors like you and me is sifting through the mountains of information that comes from the market on a daily basis. I think that may be the biggest reason that so many investors have been conditioned over the course of decades of market activity to rely on analyst […]
Read MoreOne of the big challenges for average investors is sifting through the mountains of information that comes from the market on a daily basis. I think that may be the biggest reason that so many investors have learned over the course of decades of market activity to rely on analyst estimates for a company’s future […]
Read MoreBioNTech SE (BNTX) BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer. AmpliTech Group, Inc. (AMPG) […]
Read More